CTTM03 - Quick Guide (OMS)
organisation, and click on the spyglass icon next to the organisation on the results page. This will redirect users to the organisations’ page in which the information is displayed. Once on the organisation’s page, users can select the button ‘Request change’. For users to be able to request a change to an existing organisation or to
Download CTTM03 - Quick Guide (OMS)
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
BSBMGT605 Provide leadership across the organisation
aspire-solidus-production.s3-ap-southeast-2.amazonaws.comProvide leadership across the organisation Identify relevant legislation and regulations All businesses must work within appropriate legislative requirements. There are regulations, laws and bylaws that apply to all businesses. Leaders must be aware of relevant legislation . frameworks and ensure compliance.
supplementing Directive 2014/65/EU of the European ...
ec.europa.eurequirements with respect to investment firms engaging in algorithmic trading. ... organisation of that investment firm. That self-assessment should be made regularly and should allow the investment firm to gain a full understanding of the trading systems and trading algorithms it uses and the risks stemming from algorithmic ...
MDCG 2021-19
ec.europa.euMDR and Article 82 IVDR. The organisation’s internal procedures should detail these requirements. Purchasing controls While components/parts of purchased components10 are not subject to UDI obligations unless they are regulated as medical devices in accordance with Article 23 MDR and Article
M4 Step 5 CTD for the registration of pharmaceuticals for ...
www.ema.europa.euthe technical requirements for the registration of pharmaceuticals for human use. However, until now, there has been no harmonisation of the organisation of the registration documents. Each region has its own requirements for the organisation of the technical reports in the submission and for the preparation of the summaries and tables.
REVIEW PROTOCOL TEMPLATE Recommendation 1
www.who.int6/12 Midwifery Professionals, including Public Health Midwives (ISCO-08 minor group 222, unit 2222) Dentists (ISCO-08 minor group 226, unit 2261) Pharmacists (ISCO-08 minor group 226, unit 2262) 4.2.3 Types of intervention: This is a succinct description of the types of intervention you will include.
Audit Committee Resource Guide - Deloitte
www2.deloitte.comexternal reports issued by the organisation. The key role of the audit committee is echoed in the Companies Act, 2008 (Act No 71 of 2008) (the Companies Act or the Act) and the JSE Listings Requirements. Appointment of the audit committee The Companies Act requires public companies and state owned companies to appoint an audit committee.